Oral Cladribine in Early Multiple Sclerosis (MS)

Clinical trial NCT00725985 · COMPLETED

Trial details

NCT number: NCT00725985
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-12-31
Primary completion: 2011-07-31
Enrollment: 617

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.